Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics
€ 19.00 · 4.7 (552) · In Magazzino
Delivery technologies for T cell gene editing: Applications in cancer immunotherapy - eBioMedicine
Frontiers Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer
Cancers, Free Full-Text
Cancers, Free Full-Text
Cellular Therapy in NSCLC: Between Myth and Reality
Cancers, Free Full-Text
Adoptive Cellular Therapy for Solid Tumors American Society of Clinical Oncology Educational Book
Challenges and new technologies in adoptive cell therapy, Journal of Hematology & Oncology
IJMS, Free Full-Text
A Winning New Combination? Toward Clinical Application in Oncology - Quratulain Maqsood, Aleena Sumrin, Maryam Iqbal, Nazim Hussain, Muhammada Mahnoor, Muhammad Zafar Saleem, Rukhsana Perveen, 2023
Frontiers Effect of CRISPR/Cas9-Edited PD-1/PD-L1 on Tumor Immunity and Immunotherapy
PDF) Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy
